(Q24246585)

1

0 references

D Rivetti

2

0 references

JJ Deeks

3

0 references

TO Jefferson

Cochrane Database of Systematic Reviews

4

0 references

publication date

19 July 2004

0 references

published in

0 references

cites work

Evaluation of an attenuated, cold-recombinant influenza B virus vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

Influenza Immunization: Field Trial on a University Campus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

A clinical and serologic comparison of standard and purified bivalent inactivated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

Studies of Inactivated Influenza Virus Vaccines in Hospital Employees: Reactogenicity and Absenteeism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

Clinical Trials with Alice Strain, Live, Attenuated, Serum Inhibitor-Resistant Intranasal Influenza A Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

Influenza: diagnosis, management, and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

Side Effects Associated With Influenza Vaccination in Healthy Working Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Effectiveness of influenza vaccine in health care professionals: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Preventing influenza in healthy adults: the evolving story

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

A clinical trial with Alice/R-75 strain, live attenuated serum inhibitor-resistant intranasal bivalent influenza A/B vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Do hospital employees benefit from the influenza vaccine? A placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Spared an influenza pandemic for another year?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Influenza at Christ's Hospital: March, 1974.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Live attenuated influenza virus vaccines: new options for the prevention of influenza

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Assessment of effectiveness of Vaxigrip

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Effectiveness and economical impact of vaccination against influenza among a working population in Moscow

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity and respiratory morbidity over the winter of 1997-98.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community: A report to the Medical Research Council Committee on Influenza and other respiratory virus vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

A controlled trial of inactivated monovalent influenza A vaccines in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Antibody response and reactions to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers: A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

The response to inactivated influenza A (H3N2) vaccines: the development and effect of antibodies to the surface antigens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

The Effectiveness of Vaccination against Influenza in Healthy, Working Adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Influenza vaccine efficacy in young, healthy adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980-1983

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Field trial of live attenuated influenza A/B ("Alice"/R-75) vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Evaluation of monovalent and polyvalent influenza vaccines during an epidemic of type A2 and B influenza

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Economic evaluations of influenza vaccination in healthy working-age adults. Employer and society perspective

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac in the UK.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021

Clinical trial of a subunit influenza vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001269.PUB2

7 January 2021